BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetic behavior and pharmacokinetic/pharmacodynamic integration of marbofloxacin after subcutaneous administration in goats. 2007

Samanta Waxman Dova, and M Dolores San Andrés, and Fernando González, and Manuel I San Andrés, and José J De Lucas, and Casilda Rodríguez
Cátedra de Farmacología, Facultad de Ciencias Veterinarias, Universidad de Buenos Aires, Argentina.

The pharmacokinetic behavior of marbofloxacin was studied in goats after single-dose subcutaneous (SC) administration of 2mg/kg bodyweight. Drug concentration in plasma was determined by high performance liquid chromatography and the data obtained were subjected to non-compartmental kinetic analysis. Marbofloxacin peak plasma concentration (C(max)=1.77+/-0.24microg/mL) was reached 1.25+/-0.50h (T(max)) after SC administration. The elimination half-life (t(1/2beta)) and area under curve (AUC) were 5.74+/-1.21h and 8.15 vs 2.33microg h/mL, respectively. Taking into account the values obtained for the efficacy indices, it was concluded that a SC dose of 2mg/kg/24h of marbofloxacin could be adequate to treat infections caused by high susceptible bacteria like Escherichia coli or Salmonella spp.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006041 Goats Any of numerous agile, hollow-horned RUMINANTS of the genus Capra, in the family Bovidae, closely related to the SHEEP. Capra,Capras,Goat
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone
D019540 Area Under Curve A statistical means of summarizing information from a series of measurements on one individual. It is frequently used in clinical pharmacology where the AUC from serum levels can be interpreted as the total uptake of whatever has been administered. As a plot of the concentration of a drug against time, after a single dose of medicine, producing a standard shape curve, it is a means of comparing the bioavailability of the same drug made by different companies. (From Winslade, Dictionary of Clinical Research, 1992) AUC,Area Under Curves,Curve, Area Under,Curves, Area Under,Under Curve, Area,Under Curves, Area
D024841 Fluoroquinolones A group of QUINOLONES with at least one fluorine atom and a piperazinyl group. Fluoroquinolone

Related Publications

Samanta Waxman Dova, and M Dolores San Andrés, and Fernando González, and Manuel I San Andrés, and José J De Lucas, and Casilda Rodríguez
Pharmacokinetic-pharmacodynamic integration of marbofloxacin after single and repeated intravenous administration in goats.
December 2018, Research in veterinary science,
Samanta Waxman Dova, and M Dolores San Andrés, and Fernando González, and Manuel I San Andrés, and José J De Lucas, and Casilda Rodríguez
Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin after intravenous and intramuscular administration in beagle dogs.
March 2015, Xenobiotica; the fate of foreign compounds in biological systems,
Samanta Waxman Dova, and M Dolores San Andrés, and Fernando González, and Manuel I San Andrés, and José J De Lucas, and Casilda Rodríguez
Pharmacokinetic and pharmacodynamic interactions of tolfenamic acid and marbofloxacin in goats.
February 2006, Research in veterinary science,
Samanta Waxman Dova, and M Dolores San Andrés, and Fernando González, and Manuel I San Andrés, and José J De Lucas, and Casilda Rodríguez
Pharmacokinetic-pharmacodynamic integration of orbifloxacin in rabbits after intravenous, subcutaneous and intramuscular administration.
February 2008, Journal of veterinary pharmacology and therapeutics,
Samanta Waxman Dova, and M Dolores San Andrés, and Fernando González, and Manuel I San Andrés, and José J De Lucas, and Casilda Rodríguez
Pharmacokinetic behavior and pharmacokinetic/pharmacodynamic indices of marbofloxacin after intravenous, subcutaneous, and intramuscular administrations in buffalo calves (<10 days old).
June 2012, Journal of veterinary pharmacology and therapeutics,
Samanta Waxman Dova, and M Dolores San Andrés, and Fernando González, and Manuel I San Andrés, and José J De Lucas, and Casilda Rodríguez
Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
November 2006, Antimicrobial agents and chemotherapy,
Samanta Waxman Dova, and M Dolores San Andrés, and Fernando González, and Manuel I San Andrés, and José J De Lucas, and Casilda Rodríguez
Pharmacokinetic-pharmacodynamic integration of danofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits.
February 2007, Journal of veterinary pharmacology and therapeutics,
Samanta Waxman Dova, and M Dolores San Andrés, and Fernando González, and Manuel I San Andrés, and José J De Lucas, and Casilda Rodríguez
Pharmacokinetic behavior of marbofloxacin after intravenous and intramuscular administrations in adult goats.
December 2001, Journal of veterinary pharmacology and therapeutics,
Samanta Waxman Dova, and M Dolores San Andrés, and Fernando González, and Manuel I San Andrés, and José J De Lucas, and Casilda Rodríguez
Pharmacokinetic-pharmacodynamic relationship of marbofloxacin for Escherichia coli and Pasturella multocida following repeated intramuscular administration in goats.
July 2019, Journal of veterinary pharmacology and therapeutics,
Samanta Waxman Dova, and M Dolores San Andrés, and Fernando González, and Manuel I San Andrés, and José J De Lucas, and Casilda Rodríguez
Influence of Escherichia coli endotoxin-induced fever on the pharmacokinetic behavior of marbofloxacin after intravenous administration in goats.
February 2003, Journal of veterinary pharmacology and therapeutics,
Copied contents to your clipboard!